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n spite of advances in understanding the role of the cel-
lular prion protein (PrP) in neural cell interactions, the
mechanisms of PrP function remain poorly character-
ized. We show that PrP interacts directly with the neural
cell adhesion molecule (NCAM) and associates with
NCAM at the neuronal cell surface. Both cis and trans in-
teractions between NCAM at the neuronal surface and PrP
promote recruitment of NCAM to lipid rafts and thereby
I
 
regulate activation of fyn kinase, an enzyme involved in
NCAM-mediated signaling. Cis and trans interactions be-
tween NCAM and PrP promote neurite outgrowth. When
these interactions are disrupted in NCAM-deﬁcient and
PrP-deﬁcient neurons or by PrP antibodies, NCAM/PrP-
dependent neurite outgrowth is arrested, indicating that
PrP is involved in nervous system development cooperating
with NCAM as a signaling receptor.
 
Introduction
 
The cellular prion protein (PrP) is a ubiquitous glycoprotein,
prominently expressed in the brain and localized at the cell sur-
face via a glycosylphosphatidylinositol (GPI) anchor. In prion
diseases, PrP is converted to a conformationally altered form
that accumulates in the brain (Prusiner, 1998; Weissmann and
Flechsig, 2003). Mutations in the PrP gene have been linked to
the Gerstmann-Sträussler-Scheinker syndrome, familial fatal
insomnia, sporadic Creutzfeld-Jakob disease, and certain forms
of dementia with cerebellar disorder and myopathy (Hsiao et
al., 1989; Collinge, 1997).
Attempts to identify the functions of PrP are consistent
with PrP functioning as a recognition molecule. PrP interacts or
associates with the 67-kD laminin receptor, the 37-kD laminin
receptor precursor protein, or the ECM glycoprotein laminin
(Rieger et al., 1997; Graner et al., 2000; Gauczynski et al.,
2001). PrP has been identified in a complex with the neural
cell  adhesion molecule (NCAM) by chemical cross-linking
(Schmitt-Ulms et al., 2001). However, whether PrP binds di-
rectly to NCAM has remained unclear. In addition to its protec-
tive role in models of neurodegeneration due to oxidative
stress, being probably linked to its metal ion binding ability
(Milhavet and Lehmann, 2002), PrP has been implicated in
neurite outgrowth and neuronal survival as a trans-interacting
partner, that is, an interaction between the cell surface of one
cell and a molecule from the ECM or from the cell surface of
an adjacent cell. The binding partner for PrP at the neuronal
cell surface has, however, remained elusive (Chen et al., 2003).
Similar to the molecules associated with PrP, such as laminin
and NCAM, PrP has been implicated in the physiology of neu-
rons, affecting synaptic function (Collinge et al., 1994), neurite
outgrowth, and neuronal survival (Chen et al., 2003). Because
both PrP and NCAM have been implicated in signaling cas-
cades involving the p59
 
fyn
 
 nonreceptor tyrosine kinase (fyn)
(Beggs et al., 1997; Mouillet-Richard et al., 2000) and because
fyn is involved in NCAM-induced neurite outgrowth (Beggs et
al., 1994), we investigated whether the two molecules may
functionally cooperate with each other by engaging in cis and/
or trans interactions. Furthermore, it seemed important to char-
acterize the involvement of lipid-enriched microdomains, the
so-called lipid rafts, at the cell surface as a signaling platform
for PrP, which localizes to lipid rafts because of its GPI anchor
(Gorodinsky and Harris, 1995; Walmsley et al., 2003) and for
NCAM, which can be sequestered to lipid rafts due to palmi-
toylation, which is essential for promotion of neurite outgrowth
(Niethammer et al., 2002). Here, we show that PrP interacts di-
rectly with NCAM, and in a heterophilic cis and trans configu-
ration recruits to and stabilizes NCAM in lipid rafts, thereby
activating fyn to induce NCAM-dependent neuritogenesis.
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Results
 
PrP directly interacts with NCAM
 
To obtain insights into the function of PrP in the developing
brain we first analyzed the association between PrP and
NCAM in cultured hippocampal neurons. PrP partially colocal-
ized with NCAM along neurites and in growth cones (Fig. 1 A).
As a GPI-anchored protein, PrP mostly localizes to lipid rafts
(Gorodinsky and Harris, 1995; Walmsley et al., 2003). We
therefore analyzed whether NCAM colocalizes with PrP in
lipid rafts by extracting neurons with cold 1% Triton X-100, a
procedure used to isolate cytoskeleton-bound and raft-associ-
ated proteins (Ledesma, et al., 1998; Niethammer et al., 2002;
Leshchyns’ka et al., 2003). In extracted neurons, PrP showed a
patchy distribution along neurites (Fig. 1 B) (Madore et al.,
1999), showing that PrP accumulates in subdomains at neu-
ronal plasma membranes. Similar to PrP, NCAM showed a
patchy distribution in clusters along neurites (Fig. 1 B). Clus-
ters of NCAM overlapped with PrP accumulations (mean cor-
relation between distributions of two proteins, r 
 
 
 
 0.7 
 
 
 
 0.01;
Fig. 1 D). To verify whether this overlap was specific for
NCAM, we analyzed the distribution of L1, another recogni-
tion molecule of the immunoglobulin superfamily and also
present in lipid rafts of neurites (Nakai and Kamiguchi, 2002).
In contrast to NCAM and PrP, L1 showed a more uniform dis-
tribution along extracted neurites (Fig. 1 C). The overall pat-
tern of L1 and PrP localization was different from that between
NCAM and PrP (mean correlation between distributions of L1
and PrP, r 
 
 
 
 0.27 
 
 
 
 0.02; Fig. 1, E and F).
The similar localization of NCAM and PrP suggested that
both proteins form a complex in lipid rafts. We thus cross-
linked NCAM at the neuronal surface with NCAM antibodies
applied to live neurons. NCAM clustering induced partial re-
distribution of PrP to NCAM-containing clusters (Fig. 2 A).
We also noticed nonoverlapping clusters of NCAM and PrP
(Fig. 2 A) in accordance with our observation that only a small
portion of the neuronal NCAM140 and NCAM180 isoforms is
in lipid rafts (Niethammer et al., 2002). To further investigate
this phenomenon, we analyzed by an ELISA binding assay
whether PrP and NCAM directly interact using recombinant
PrP-Fc, which contains the extracellular domain of mouse PrP
fused to the Fc portion of IgG (Chen et al., 2003), and NCAM
purified from mouse brain. NCAM bound to PrP-Fc in a con-
centration-dependent manner, but not to BSA (Fig. 2 B). L1
also did not bind to PrP (Fig. 2 B), in accordance with results
with extracted neurons (Fig. 1). NCAM is the carrier of poly-
sialic acid (PSA), which may influence its binding to PrP. To
verify whether PSA influences binding to PrP, we analyzed by
ELISA the interaction between PrP and nonpolysialylated
NCAM-Fc produced in CHO cells using recombinant PrP-AP,
which contains the extracellular domain of PrP fused to alka-
line phosphatase (Chen et al., 2003). We found that nonpoly-
sialylated NCAM-Fc also bound to PrP-AP in a concentration-
dependent manner, but not to BSA (Fig. 2 C).
To investigate whether NCAM and PrP interact in brain
tissue, we immunoprecipitated NCAM from brain homoge-
nates and analyzed immunoprecipitates with antibodies against
PrP. PrP coimmunoprecipitated with NCAM (Fig. 2 E), indi-
cating that the two proteins are associated in brain. Another
GPI-anchored immunoglobulin superfamily recognition mole-
cule, F3/contactin, did not coimmunoprecipitate with NCAM,
underscoring the specificity of NCAM interaction with PrP
(Fig. 2 E).
Next, we examined whether NCAM and PrP exist in a
complex in the same plasma membrane microenvironment
by inducing covalent binding between primary amino groups
of adjacent proteins in the lipid raft fraction from total brain
Figure 1. NCAM colocalizes with PrP in lipid rafts. (A) Neurite with two
growth cones (arrows) double-labeled with NCAM and PrP antibodies.
PrP and NCAM partially colocalize along neurites and in growth cones.
(B and C) Neurons were extracted in cold 1% Triton X-100 and labeled
with PrP and NCAM antibodies (B) or PrP and L1 antibodies (C). Detergent-
insoluble clusters of PrP overlap with accumulations of NCAM. L1 shows a
distribution distinct from PrP. Bars, 10  m. (D and E) Examples of linear
regression graphs comparing distributions of PrP and NCAM (D) or PrP
and L1 (E) are shown. Corresponding correlation coefficients (r) are
presented. (F) The diagram shows mean correlation coefficients (r) com-
paring distributions of PrP and NCAM or PrP and L1. The correlation
between localization of NCAM and PrP is significantly higher than be-
tween localization of L1 and PrP. Mean values   SEM (n    30) are
shown. *, P   0.05, t test. 
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homogenates using the homobifunctional BS
 
3
 
 chemical cross-
linker with a spacer arm of 11.4 Å. It has been shown repeat-
edly that BS
 
3
 
 does not trigger nonspecific protein clustering
(Bhamidipati et al., 2000; Culligan et al., 2001; Kaykas et al.,
2004). In Western blots of cross-linked probes, PrP was ob-
served in high molecular weight complexes as a PrP-positive
band above 200 kD (Fig. 2 F). NCAM was also shifted to a
higher molecular weight when compared with its molecular
weight before cross-linking (Fig. 2 F). The high molecular
weight PrP and NCAM immunoreactive bands overlapped
(Fig. 2 F), suggesting PrP cross-linking with NCAM. Similar
results were observed when isolated membrane fractions were
used for cross-linking (unpublished data). To estimate the
amount of NCAM complexing with PrP in brain membranes,
we immunoprecipitated PrP from the cross-linked membranes.
NCAM was coimmunoprecipitated with PrP (Fig. 2 G). Ap-
proximately 10% of all NCAM immunoreactivity was ob-
served in this complex, corresponding to NCAM levels in lipid
rafts (Niethammer et al., 2002). We conclude that NCAM in-
teracts with PrP and that both molecules form a complex in
neuronal cell surfaces.
 
PrP is involved in stabilization of NCAM 
in lipid rafts
 
NCAM140 and NCAM180 localize mostly to raft-free areas
and redistribute to lipid rafts through palmitoylation of NCAM
after NCAM activation (Niethammer et al., 2002; Lesh-
chyns’ka et al., 2003). Because PrP localizes to lipid rafts,
complex formation between NCAM and PrP should occur in
lipid rafts. We thus hypothesized that interaction of NCAM
with PrP may recruit NCAM to and stabilize it in lipid rafts. In-
deed, absence of PrP in PrP
 
 
 
/
 
 
 
 brains reduced the amount of
NCAM140 and NCAM180 in lipid rafts (76.4 
 
 
 
 6.7% in PrP
 
 
 
/
 
 
 
lipid rafts with PrP
 
 
 
/
 
 
 
 values set to 100%; Fig. 3 A) and growth
cones (66.13 
 
 
 
 10% in PrP
 
 
 
/
 
 
 
 lipid rafts with PrP
 
 
 
/
 
 
 
 values set
to 100%; Fig. 3 A). The GPI-anchored and lipid raft–localized
NCAM120 was present in similar amounts in lipid rafts iso-
lated from PrP
 
 
 
/
 
 
 
 and PrP
 
 
 
/
 
 
 
 brains, indicating that lipid rafts
were isolated with the same efficacy. Levels of L1 were similar
in lipid rafts isolated from brains of PrP
 
 
 
/
 
 
 
 and PrP
 
 
 
/
 
 
 
 mice
(Fig. 3 B), confirming that PrP deficiency does not affect the
overall raft composition. In contrast, overall levels of NCAM
were increased in PrP
 
 
 
/
 
 
 
 brains (Fig. 3 A), excluding the possi-
Figure 2. NCAM directly interacts with PrP. (A) Neurons
incubated live with antibodies against NCAM to induce
clustering of NCAM at the cell surface were fixed and
labeled with antibodies against PrP. PrP partially redis-
tributed to NCAM clusters (arrows). Bar, 10  m. (B) In-
creasing concentrations of NCAM and L1, purified from
mouse brain, were assayed by ELISA for their binding to
plastic-bound PrP-Fc (5  g/ml). Binding of NCAM to BSA
(3 mg/ml) served as a control. Mean values (OD405)  
SEM (n   6) are shown. (C) Increasing concentrations of
NCAM-Fc were assayed by ELISA for their binding to
plastic-bound PrP-AP (5  g/ml). Binding of NCAM-Fc to
BSA (3 mg/ml) served as a control. Mean values (OD405)  
SEM (n   6) are shown. (D) NCAM from mouse brain
and NCAM-Fc were immunoblotted (WB) with antibodies
against NCAM and polysialic acid (PSA). Note that PSA
immunoreactivity is found only on NCAM purified from
mouse brain. The two bottom bands represent degradation
products of NCAM-Fc (asterisk). (E) NCAM immunopre-
cipitates from the NCAM
 /  mouse brain were immuno-
blotted (WB) with PrP or F3 antibodies. NCAM
 /  brains
served as a control for PrP immunoprecipitation. Brain
homogenate (hom.) was also probed for F3. PrP, but not
F3, coimmunoprecipitated with NCAM. (F) Lipid rafts (S)
or lipid rafts treated with BS
3 (BS
3) were immunoblotted
with PrP antibodies (WB: PrP). Then, the membrane was
stripped and labeled with NCAM antibodies (WB:
NCAM). Note a PrP-immunoreactive band above 200 kD
in the cross-linked material that overlaps with a shifted
NCAM immunoreactive band (arrows). (G) Total mem-
branes (S) or PrP immunoprecipitates from total mem-
branes treated with BS
3 (IP: PrP) were immunoblotted
(WB) with antibodies to NCAM, PrP, and L1. Immunopre-
cipitation performed with nonimmune IgG served as a
control (IP: IgG). Note that NCAM, but not L1, coimmuno-
precipitated with PrP. 
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bility that reduced levels of NCAM140 and NCAM180 in lipid
rafts are due to reduced expression of NCAM in PrP
 
 
 
/
 
 
 
 brains.
We conclude that PrP is involved in stabilization of NCAM140
and NCAM180 in lipid rafts.
 
Cis and trans interactions between PrP 
and NCAM are important for NCAM 
stabilization in lipid rafts
 
Two distinct types of interaction between PrP and NCAM
could account for the observed phenomena. PrP could stabilize
NCAM in lipid rafts by cis interaction, i.e., both molecules as-
sociate in the plasma membrane of the same neuron. In accor-
dance with this idea, NCAM and PrP were cross-linked with
antibodies at live neuronal cell surfaces (Fig. 2 A). Chemical
cross-linking of NCAM and PrP was also performed in low
density cultures allowing only cis interactions between NCAM
and PrP (unpublished data). To analyze the cis interaction in
lipid rafts, we estimated the amount of detergent-insoluble
NCAM in PrP
 
 
 
/
 
 
 
 and PrP
 
 
 
/
 
 
 
 cultured hippocampal neurons.
Only neurons without contacts were evaluated to assure that
only cis interactions were analyzed. PrP
 
 
 
/
 
 
 
 neurons extracted
with cold Triton X-100 showed lower NCAM labeling inten-
sity in NCAM clusters and along neurites when compared with
PrP
 
 
 
/
 
 
 
 neurons, indicating a reduction of NCAM in lipid rafts
(Fig. 4, C and D). This reduction was not due to a decrease in
expression of NCAM in PrP
 
 
 
/
 
 
 
 neurons because the mean la-
beling intensity of NCAM along neurites of nonextracted
neurons was increased in PrP
 
 
 
/
 
 
 
 neurons (Fig. 4, A and B), in
accordance with our biochemical data (Fig. 3 A). We conclude
that cis interactions between NCAM and PrP are important for
stabilization of NCAM in lipid rafts.
PrP could also induce redistribution of NCAM to lipid
rafts by trans interaction, i.e., NCAM binds to PrP on adjacent
cells. To analyze the role of a trans interaction between NCAM
and PrP, we applied soluble PrP-Fc to neurons from PrP
 
 
 
/
 
 
 
mice to evaluate the redistribution of NCAM to lipid rafts in
Figure 3. Targeting of NCAM to lipid rafts is reduced in
PrP
 /  mice. (A) Brain homogenates or lipid rafts from
brain homogenates and growth cones of PrP
 /  and
PrP
 /  mice (0–4 d old) were immunoblotted (WB) with
antibodies against NCAM. The band at and above 180
kD represents polysialylated NCAM140 and NCAM180
(PSA-NCAM; Niethammer et al., 2002). In lipid rafts, a
band representing nonpolysialylated NCAM120 is also
observed. Diagrams show quantitation of PSA-NCAM
and NCAM120. Note that the amount of PSA-NCAM is
increased in brain homogenates and decreased in rafts
isolated from brain homogenates and growth cones of
PrP
 /  mice. (B) Lipid rafts isolated from brain homoge-
nates of PrP
 /  and PrP
 /  mice (0–4 d old) were immu-
noblotted with L1 antibodies. Diagrams show quantitation
of L1. Note that the amount of L1 is similar in rafts iso-
lated from PrP
 /  and PrP
 /  mice. Mean values   SEM
(n   6) are shown. AU   arbitrary units. *, P   0.05,
paired t test (for A and B). 
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absence of NCAM-to-PrP cis interaction. Covalent chemical
cross-linking of PrP-Fc with NCAM in brain homogenates indi-
cated that PrP-Fc indeed bound to endogenous NCAM in a
trans fashion (unpublished data). Application of PrP-Fc in-
creased the detergent-insoluble NCAM fraction in NCAM
clusters and along neurites of PrP
 
 
 
/
 
 
 
 neurons (Fig. 4, E and F).
Because increase of NCAM levels in lipid rafts after application
of PrP-Fc suggested a PrP-Fc–induced redistribution of NCAM
to lipid rafts, we measured the association of NCAM with lipid
rafts in response to PrP-Fc application in PrP
 
 
 
/
 
 
 
 neurons using
the PI(4,5)P
 
2
 
 raft marker (Laux et al., 2000; Niethammer et al.,
2002). Amounts of PI(4,5)P
 
2
 
 in detergent-insoluble NCAM
clusters were increased after PrP-Fc application, indicating that
PrP-Fc redistributed NCAM to lipid rafts (Fig. 4, G and H). The
same result was obtained when endogenous PrP or ganglioside
GM1 (Leshchyns’ka et al., 2003) were taken as raft markers
(unpublished data). As for PrP
 
 
 
/
 
 
 
 neurons, application of PrP-
Fc to PrP
 
 
 
/
 
 
 
 neurons increased levels of detergent insoluble
NCAM in NCAM clusters and along neurites (Fig. 4, G and H).
We conclude that trans interaction of PrP with NCAM induces
redistribution of NCAM to lipid rafts.
NCAM activation with NCAM-Fc or NCAM antibodies
induces redistribution of NCAM to lipid rafts being neces-
sary for NCAM-mediated neurite outgrowth (Niethammer et
al., 2002; Leshchyns’ka et al., 2003). Indeed, NCAM-Fc or
NCAM antibodies increased PrP levels in NCAM clusters in
PrP
 
 
 
/
 
 
 
 neurons (Fig. 5, A and C), indicating that NCAM par-
tially redistributes to lipid rafts as previously observed (Lesh-
chyns’ka et al., 2003), and suggesting that association between
NCAM and PrP is enhanced after NCAM activation. In spite of
Figure 4. Cis and trans interactions between
NCAM and PrP distribute NCAM to lipid rafts.
(A and B) PrP
 /  and PrP
 /  neurons were la-
beled with NCAM antibodies. Note enhanced
levels of NCAM on PrP
 /  neurites. (B) Dia-
gram shows mean labeling intensity of NCAM
along neurites. (C and D) PrP
 /  and PrP
 / 
neurons extracted in cold 1% Triton X-100
were labeled with NCAM antibodies. Note re-
duced levels of detergent-insoluble NCAM on
PrP
 /  neurites. (D) Diagrams show mean
NCAM labeling intensity in NCAM clusters
and along total neurites of PrP
 /  and PrP
 / 
neurons. (E and F) PrP
 /  neurons were incu-
bated with PrP-Fc, extracted in cold 1% Triton
X-100, and labeled with NCAM antibodies.
Note increased levels of detergent insoluble
NCAM on neurites exposed to PrP-Fc when
compared with the nonexposed group (con-
trol). (F) Diagrams show mean NCAM label-
ing intensity in NCAM clusters and along neu-
rites of untreated and PrP-Fc–treated PrP
 / 
neurons. (G and H) NCAM
 /  neurons were
incubated with PrP-Fc, extracted in cold 1%
Triton X-100, and labeled with antibodies
against NCAM and PI(4,5)P2. Examples of
distributions of NCAM and PI(4,5)P2 labeling
intensity along neurites of control and PrP-Fc–
incubated groups are shown. Arrows show
overlapping peaks. Note increased overlap of
detergent-insoluble NCAM and PI(4,5)P2 after
incubation with PrP-Fc. (H) Diagrams show
mean labeling intensity of PI(4,5)P2 in NCAM
clusters in control and PrP-Fc–treated groups
and mean NCAM labeling intensity in NCAM
clusters and along neurites. Mean values  
SEM are shown in arbitrary units (AU) (n  
50 neurites). *, P   0.05, t test. Bar, 10  m
(for A–G).JCB • VOLUME 169 • NUMBER 2 • 2005 346
overall higher levels of NCAM expression in PrP
 /  neurons
(Fig. 4, A and B), NCAM levels in lipid rafts were reduced in
stimulated PrP
 /  neurons (Fig. 5, B and D), indicating that cis
interactions between NCAM and PrP are important for redistri-
bution of NCAM to lipid rafts in response to NCAM activation.
Activation of the fyn kinase is reduced in 
PrP
 /  mice
Accumulation of NCAM in lipid rafts is necessary for NCAM-
mediated neurite outgrowth and implies activation of the fyn
kinase pathway (Niethammer et al., 2002). Total levels of fyn
kinase immunoprecipitable from brain homogenates and lipid
rafts of PrP
 /  mice were increased when compared with PrP
 / 
mice (Fig. 6). However, levels of activated fyn were reduced in
PrP
 /  brain homogenates (ratio of activated fyn to the total
fyn protein was 59.4   15.3% for PrP
 /  brains with PrP
 /  set
to 100%) and lipid rafts (ratio of activated fyn to the total fyn
protein was 26.7   9.8% for PrP
 /  rafts with PrP
 /  set to
100%). Because fyn forms a complex with NCAM (Beggs et al.,
1997) and NCAM redistribution to lipid rafts activates NCAM-
mediated fyn signaling (Niethammer et al., 2002; Bodrikov et
al., 2005), reduction of activated fyn in PrP
 /  brains could be
due to reduction of activated fyn associated with NCAM.
To analyze this, we studied whether redistribution of
NCAM to lipid rafts in response to stimulation with PrP-Fc
would affect levels of activated fyn. Indeed, application of PrP-
Fc to PrP
 /  neurons increased levels of activated fyn along
neurites and in NCAM clusters (Fig. 7, A and B). When PrP-Fc
was applied to PrP
 /  neurons, levels of activated fyn were also
significantly increased along neurites and in NCAM clusters
(Fig. 7, A and B), indicating that trans interactions between
NCAM and PrP induce fyn activation. However, the efficacy
of fyn activation was lower in PrP
 /  cells (200 and 140%
along neurites of stimulated PrP
 /  and PrP
 /  cells, respec-
tively, with the level of activated fyn in control cells set to
100%), suggesting that cis interactions between NCAM and
PrP are also important for fyn activation. To confirm this, we
analyzed activation of fyn in response to NCAM-Fc in PrP
 / 
neurons, thereby excluding cis interactions between NCAM
and PrP. Application of NCAM-Fc increased levels of activated
Figure 5. PrP is required for redistribution of NCAM to
lipid rafts in response to NCAM activation. (A) PrP
 /  neu-
rons were incubated with NCAM-Fc or polyclonal NCAM
antibodies, extracted with 1% Triton X-100, and labeled
with NCAM and PrP antibodies. Incubation with NCAM-Fc
and NCAM pAb increased the overlap between NCAM
and PrP, indicating that NCAM redistributed to lipid rafts.
Examples of NCAM and PrP labeling intensities along
neurites are shown below. Arrows show overlapping
peaks. (B) In parallel with PrP
 /  neurons (A), PrP
 / 
neurons  were incubated with NCAM-Fc or polyclonal
NCAM antibodies (NCAM pAb), extracted with 1% Triton
X-100, and labeled with NCAM antibodies. Note lower
levels of detergent-insoluble NCAM in untreated (control),
NCAM-Fc–, and NCAM pAb–treated PrP
 /  versus PrP
 / 
neurites. Bars, 10  m (for A and B). (C) Diagrams show
mean labeling intensity of PrP in NCAM clusters in control
and NCAM-Fc– or NCAM pAb–incubated PrP
 /  neurons.
(D) Diagrams show mean NCAM labeling intensity in
NCAM clusters and along neurites of NCAM-Fc– or
NCAM pAb–treated PrP
 /  and PrP
 /  neurons. Mean
values   SEM (n   50 neurites) are shown (for C and D).
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fyn in NCAM clusters and along neurites of PrP
 /  neurons
(150% along neurites of stimulated neurons, with the level of
activated fyn in control cells set to 100%; Fig. 7 B). However,
in PrP
 /  neurons levels of activated fyn were not changed in
response to NCAM-Fc, indicating that cis interactions between
NCAM and PrP are required for NCAM-mediated fyn acti-
vation (Fig. 7 B). Levels of GM1 were similar in neurites of
PrP
 /  and PrP
 /  neurons (Fig. 7 C), excluding that reduced
activation of fyn in PrP
 /  neurons was due to reduced levels of
lipid rafts in PrP
 /  neurites. As control, nonspecific clustering
of GM1 containing lipid rafts with cholera toxin (Harder et al.,
1998) did not activate fyn (Fig. 7 D). To further confirm that
NCAM is the major neuronal receptor required for PrP-medi-
ated fyn activation, we analyzed activation of fyn in response
to PrP-Fc application to NCAM
 /  neurons: levels of activated
fyn along neurites of NCAM
 /  neurons were not changed
(Fig. 7 E), indicating that NCAM is required for PrP-Fc in-
duced fyn activation. In agreement, polyclonal PrP antibodies
did not activate fyn, indicating that clustering of PrP alone is
insufficient to activate fyn (Fig. 7 F). Interestingly, PrP anti-
bodies completely inhibited NCAM-Fc–induced fyn activation
(Fig. 7 F), probably by interfering with cis interaction between
NCAM and PrP. Finally, levels of activated fyn coimmunopre-
cipitated with NCAM were also approximately two times
lower in PrP
 /  brains when compared with PrP
 /  brains (un-
published data), despite the overall increase of NCAM expres-
sion in PrP
 /  brains. We conclude that NCAM is the receptor
for PrP in trans and cooperates with PrP in cis to activate fyn.
Coexpression of NCAM140 with PrP 
enhances targeting of NCAM140 to lipid 
rafts and fyn activation in CHO cells
To exclude that enzymes responsible for NCAM palmitoylation
or fyn activation were nonspecifically affected by PrP ablation,
we investigated whether PrP expression in PrP-negative CHO
cells would affect NCAM140 targeting to lipid rafts and fyn ac-
tivation. CHO cells were stably transfected with NCAM140 or
PrP alone or cotransfected with NCAM140 and PrP. In low den-
sity CHO cell cultures and thus absence of trans interactions be-
tween NCAM and PrP, levels of NCAM140 were higher in lipid
rafts from cells cotransfected with NCAM140 and PrP when
compared with NCAM140-only transfected cells (Fig. 8 A), fur-
ther confirming that cis interactions between NCAM140 and
PrP target NCAM140 to lipid rafts. Application of PrP-Fc to
NCAM140-transfected cells increased levels of NCAM140 in
lipid rafts (Fig. 8 C), indicating that trans interactions between
NCAM and PrP also target NCAM140 to lipid rafts. Further-
more, both types of interactions increased levels of activated fyn
in the cells (Fig. 8, B and D).
NCAM interaction with PrP enhances 
NCAM-mediated neurite outgrowth
Redistribution of NCAM to lipid rafts in response to NCAM ho-
mophilic binding is required for NCAM-mediated neurite out-
growth (Niethammer et al., 2002; Leshchyns’ka et al., 2003). In
this paradigm, substrate-coated or soluble NCAM interacts with
and signals through NCAM at the neuronal cell surface. Be-
cause the binding of PrP-Fc to NCAM also redistributes NCAM
lipid rafts (Fig. 4 G), we investigated whether PrP-Fc promotes
NCAM-mediated neurite outgrowth. PrP-Fc was thus applied to
cultured hippocampal neurons and neurite length was measured
after 24 h. PrP-Fc increased neurite lengths when compared
with the control group (Fig. 9 A) as previously observed (Chen
et al., 2003), suggesting that PrP-Fc–induced redistribution of
NCAM to lipid rafts promotes neurite outgrowth. Alternatively,
clustering of GPI-anchored raft-associated proteins may also ac-
tivate intracellular signaling cascades, leading to enhanced neu-
rite outgrowth (Doherty et al., 1993). To exclude the possibility
Figure 6. Activation of fyn kinase is reduced in PrP
 /  mice. Fyn was
immunoprecipitated from brain homogenates or lipid rafts of 0–4-d-old
PrP
 /  and PrP
 /  mice. Brain homogenates (A), lipid rafts (D), and immu-
noprecipitates from brain homogenates (B and C) or lipid rafts (E and F)
were analyzed by immunoblotting (WB) with antibodies against fyn protein
and activated Tyr416 phosphorylated fyn. Note that levels of fyn protein
are increased in brain homogenates, lipid rafts, and immunoprecipitates
from PrP
 /  mice, whereas levels of activated fyn are decreased. Diagrams
with quantitation of immunoblots are shown below. Mean values   SEM
(n   6) are shown. AU   arbitrary units. *, P   0.05, paired t test.JCB • VOLUME 169 • NUMBER 2 • 2005 348
that PrP-Fc acts via clustering of PrP at cell surfaces and not via
NCAM, we incubated neurons with different concentrations of
polyclonal PrP antibodies, thereby clustering PrP at the cell sur-
face. Unexpectedly, we found that PrP antibodies inhibited neu-
rite outgrowth (Fig. 9 B), indicating that clustering of PrP is not
sufficient to induce neurite outgrowth. Furthermore, it sug-
gested that PrP antibodies inhibit cis interactions between PrP
and a binding partner at the cell surface that was required for
neurite outgrowth. To directly assess the role of NCAM in
PrP-Fc–induced  neurite outgrowth, we treated NCAM
 / 
neurons with PrP-Fc and found that, in contrast to NCAM
 / 
neurons, NCAM
 /  neurons did not respond to PrP-Fc (Fig. 9
C), confirming that NCAM is a major receptor for PrP in PrP-
Fc–induced neurite outgrowth. To analyze the role of PrP-to-
NCAM trans interaction in NCAM-mediated neurite outgrowth,
we estimated neurite outgrowth in response to PrP-Fc in PrP
 / 
neurons, thereby abolishing cis interactions between NCAM
and PrP. PrP-Fc enhanced neurite lengths (Fig. 9 D), indicating
that trans interactions between NCAM and PrP are involved in
promoting neurite outgrowth. To analyze the role of cis interac-
tions between NCAM and PrP in NCAM-mediated neurite out-
growth, we compared neurite outgrowth in response to NCAM
activation in PrP
 /  neurons transfected with GFP alone or GFP
together with PrP. Transfected PrP was delivered to the cell sur-
face and partially colocalized with NCAM (unpublished data).
In GFP-transfected neurons, treatment with NCAM-Fc en-
hanced neurite outgrowth when compared with Fc-treated cells
(controls), indicating PrP-independent response to NCAM.
However, PrP-transfected neurons treated with NCAM-Fc pro-
duced even longer neurites (Fig. 9 E). This increase in the
NCAM-Fc–elicited response thus evolves from an NCAM-to-
PrP cis interaction. Furthermore, PrP antibodies completely
abolished the NCAM-Fc–induced response in wild-type neu-
rons (Fig. 9 F), probably by interfering with cis interactions
Figure 7. PrP-Fc activates fyn via its neu-
ronal receptor NCAM. (A) PrP
 /  and PrP
 / 
neurons were incubated with PrP-Fc, extracted
with 1% Triton X-100, and labeled with anti-
bodies against NCAM and activated Tyr416
phosphorylated fyn. Note increased levels of
activated fyn in NCAM clusters on PrP-Fc–
treated PrP
 /  and PrP
 /  neurites. Note lower
levels of the activated fyn in PrP
 /  neurons.
Bar, 10  m. (B) Application of PrP-Fc in-
creased levels of activated fyn in PrP
 /  and
less in PrP
 /  neurons. Application of NCAM-
Fc increased levels of activated fyn in PrP
 / 
but not PrP
 /  neurons. (C) Mean labeling in-
tensity of GM1 along neurites of PrP
 /  and
PrP
 /  neurons extracted with 1% Triton X-100
is shown. (D) Aggregation of lipid rafts with
cholera toxin (CTX) did not increase levels of
activated fyn in PrP
 /  neurites. (E) Applica-
tion of PrP-Fc increased levels of activated
fyn in NCAM
 /  but not NCAM
 /  neurites.
(F)  Application of polyclonal PrP antibodies
before NCAM-Fc application blocked NCAM-
Fc–induced fyn activation. (B, D–F) Diagrams
show increase in mean labeling intensity of
activated fyn along neurites. Mean labeling in-
tensity of activated fyn in control neurites was
taken as 100%. Mean values   SEM (n   50
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between NCAM and PrP at the cell surface and with fyn activa-
tion (Fig. 7). The combined observations indicate that NCAM is
a major neuronal receptor for PrP presented in a trans fashion.
We also conclude that cis interactions between NCAM and PrP
at the neuronal cell surface enhance NCAM-induced neurite out-
growth when NCAM is presented to neurons in a trans fashion.
Discussion
In this study we have shown that PrP and NCAM are not only
associated with each other at the surface of hippocampal neu-
rons, but also directly interact with each other—features that
have not been described previously. We also showed that the
GPI-linked PrP that cannot interact directly with intracellular
signaling pathways recruits to and stabilizes the transmem-
brane NCAM isoforms in lipid-rich microdomains to activate
fyn and promote NCAM-mediated neurite outgrowth by cis
and trans interactions.
Transmembrane recognition molecules are often segre-
gated from their signaling cascades by colocalizing receptors
and their downstream effectors to distinct membrane subdo-
mains, such as lipid rafts. The mechanisms that collect recep-
tors to their signaling platforms have only started to emerge.
We show that NCAM uses its PrP-guided enrichment in lipid
rafts to activate fyn, which becomes associated with lipid rafts
rapidly after synthesis (van’t Hof and Resh, 1997; Filipp et
al., 2003). Interestingly, although the intracellular domain of
NCAM does not contain sequences known to activate fyn, it di-
rectly associates with the receptor type protein phosphatase  
(RPTP ), a fyn activator. At resting conditions, when not stim-
ulated by cis or trans interactions, NCAM and RPTP  are seg-
regated from fyn, which localizes to rafts. In response to
NCAM activation NCAM binds RPTP  and both molecules
are recruited to lipid rafts where RPTP  activates fyn (Bo-
drikov et al., 2005), a process that is regulated by PrP (Fig. 10).
It is important in this respect that, in contrast to other GPI-
anchored molecules such as Thy-1 (Doherty et al., 1993), clus-
tering of PrP alone with PrP antibodies is not sufficient to induce
neurite outgrowth but rather inhibits it by interfering with cis
interactions between NCAM and PrP. Because PrP-Fc–induced
fyn activation and neurite outgrowth are largely inhibited in
NCAM
 /  cells, the most plausible explanation is that NCAM
is a major PrP receptor. These observations merge two previ-
ously separate venues of investigation, namely the requirement
of NCAM to be localized to lipid rafts to induce neurite out-
growth via fyn activation together with FGF receptor activation
(Niethammer et al., 2002) and the proposed activation of fyn
kinase (Mouillet-Richard et al., 2000) by PrP, which binds to
an unknown surface receptor (Chen et al., 2003). Whether
NCAM cooperates with the laminin receptor, which is another
surface receptor for PrP (Gauczynski et al., 2001), or whether
PrP–laminin receptor interactions have distinct functions in
neurite outgrowth remains to be investigated.
Remarkably, not only binding of NCAM to PrP in the
neuronal plasma membrane (cis interaction), but also binding
of NCAM to PrP in trans interaction, redistributes NCAM to
lipid rafts. It is thus interesting that besides its lipid domain–
Figure 8. Cis and trans interactions between NCAM140 and PrP in-
crease targeting of NCAM140 to lipid rafts and fyn activation in CHO cells.
(A and B) Lipid rafts (A) or fyn immunoprecipitates from lipid rafts (B)
from low density cultures of nontransfected CHO cells or CHO cells sta-
bly transfected with NCAM140, PrP, or cotransfected with NCAM140
and PrP were analyzed by immunoblotting (WB) with antibodies to
NCAM, fyn protein, and Tyr416-phosphorylated fyn. Note that levels of
NCAM140 and activated fyn are increased in lipid rafts from CHO cells
cotransfected with NCAM140 and PrP, but not singly transfected cells.
(C and D) Confluent cultures of nontransfected and NCAM140-trans-
fected CHO cells were incubated with Fc or PrP-Fc. Lipid rafts (C) or fyn
immunoprecipitates from lipid rafts (D) were analyzed by immunoblotting
(WB) with antibodies to NCAM, fyn protein, and Tyr416-phosphorylated
fyn. Note that levels of NCAM140 and activated fyn are increased after
incubation with PrP-Fc in NCAM140-transfected cells. Slightly increased
basal levels of activated fyn in control NCAM140 transfected cells com-
pared with nontransfected cells are induced by trans interactions between
NCAM molecules in these cultures (Niethammer et al., 2002). Immunola-
beling for fyn (A and C) shows that lipid rafts were isolated with the same
efficiency. Diagrams with quantitation of immunoblots (A–D) are shown
below. Mean values   SEM (n   6) are shown. AU   arbitrary units.
*, P   0.05, paired t test.JCB • VOLUME 169 • NUMBER 2 • 2005 350
targeting GPI anchor, PrP may associate in trans interaction
with lipid rafts via its ectodomain (Walmsley et al., 2003) and
thereby may additionally recruit NCAM to lipid rafts. It is also
conceivable that NCAM uses other signal transduction path-
ways independent of PrP and PrP’s ability to recruit NCAM to
lipid rafts for signal transduction. Because abnormalities in
PrP
 /  mice have been described as undetectable or mild, al-
though closer scrutiny has identified abnormalities, it is conceiv-
able that triggered palmitoylation of NCAM and/or recruitment
of NCAM to other signaling platforms may compensate for
some PrP functions.
Functional interactions of PrP with its binding partner(s)
have been suggested previously (Telling et al., 1995; Shmer-
ling et al., 1998): a cis- and/or trans-interacting PrP activates an
unknown binding partner competing with the dominant-nega-
tive mutant of PrP truncated at the amino terminus, leading to
ataxia and cerebellar lesions (Shmerling et al., 1998). We have
now identified NCAM as binding partner for PrP that can co-
operate with PrP in neurite outgrowth. It is likely that coop-
eration between these molecules also occurs in the adult. It is
thus noteworthy that both molecules modify synaptic activity
(Collinge et al., 1994; Cremer et al., 1994; Luthi et al., 1994;
Mallucci et al., 2002). Interestingly, defects in NCAM- and
PrP-dependent regulation of synaptic activity may not only be
due to developmental abnormalities, but are seen in mice con-
ditionally ablated for NCAM and PrP expression at a juvenile
state (Mallucci et al., 2002; Bukalo et al., 2004). Furthermore,
mutations in PrP in both humans and mice lead to abnormal
sleep patterns, resulting in fatal familial insomnia in humans
(Gambetti et al., 2003). Likewise, NCAM is involved in regu-
lation of circadian body functions by entraining glutamatergic
activity of the suprachiasmatic nuclei to the solar day in photic
and nonphotic settings (Kleene and Schachner, 2004). These
finding are remarkable in view of PrP and NCAM signaling
through fyn, which is also implicated in synaptic functions
(Grant et al., 1992; Kojima et al., 1997).
Figure 9. NCAM-mediated neurite outgrowth depends
on PrP. (A and B) Wild-type hippocampal neurons were
incubated with PrP-Fc (A) or polyclonal PrP antibodies (B).
Note enhanced neurite outgrowth after PrP-Fc application
and reduced neurite outgrowth after incubation with poly-
clonal PrP antibodies. (C and D) NCAM
 /  (C) or PrP
 / 
(D) neurons were incubated with PrP-Fc. PrP-Fc increased
neurite lengths in PrP
 /  but not NCAM
 /  neurons. (E)
Neurons from PrP
 /  mice transfected with GFP alone or
cotransfected with GFP and PrP were incubated with
NCAM-Fc after transfection. NCAM-Fc increased neurite
lengths of GFP-transfected neurons. NCAM-Fc–stimulated
neurite outgrowth was further increased in neurons
cotransfected with PrP. (F) PrP
 /  neurons were incubated
with NCAM-Fc and NCAM-Fc together with polyclonal
PrP antibodies. Note inhibition of NCAM-Fc–induced
neurite outgrowth after incubation with PrP antibodies.
Lengths of longest neurites were measured and mean
values   SEM are shown (n   150 neurons, *, P   0.05,
t test, for A–F).FUNCTIONAL INTERACTIONS BETWEEN PRP, NCAM, AND FYN • SANTUCCIONE ET AL. 351
Finally, consequences of the trans and cis interactions be-
tween NCAM and PrP for transmissible and nontransmissible
prion diseases, leading to infectious propagation of the mutation
with its loss-of-function or gain-of-function consequences,
should be viewed in the context of PrP interacting heterophili-
cally with other molecules, such as NCAM. Interestingly, the in-
cubation period of the scrapie conformer of prion protein (PrP
Sc)
is not altered in NCAM
 /  mice compared with NCAM
 / 
mice, suggesting that NCAM does not affect PrP
Sc formation
(Schmitt-Ulms et al., 2001). Also, it has been excluded that neu-
rodegeneration occurs because of PrP deficiency (Mallucci et
al., 2002). It is thus conceivable that interactions between PrP
and NCAM are reduced by accumulation of PrP
Sc in the dis-
eased nervous system. A reduced association between PrP and
NCAM could also be caused by application of PrP antibodies
that trigger rapid and extensive apoptosis in hippocampal and
cerebellar neurons in vivo (Solforosi et al., 2004). Similarly, we
found that application of PrP antibodies abrogates NCAM-
induced neurite outgrowth. It is tempting to speculate that inter-
ference with NCAM-mediated signaling in the diseased brain
may favor cell death and inhibit synaptic plasticity-related neu-
ritogenesis. Because NCAM, on the one hand, and PrP, on the
other, interact with different sets of cell surface and ECM mole-
cules, the interplay of these interactions during development and
in the adult brain will be the target of further investigations.
Materials and methods
Antibodies
Rabbit pAbs against the extracellular domain of NCAM (Niethammer et
al., 2002) were used in immunoprecipitation, immunoblotting, and immu-
nocytochemical experiments and rat mAbs H28 against mouse NCAM
(Gennarini et al., 1984) were used in immunocytochemical experiments.
Both antibodies react with the three major isoforms of NCAM. Hybridoma
clone H28 was provided by Dr. Christo Goridis (CNRS UMR 8542, Paris,
France). Mouse mAbs 8H4 and rabbit pAbs 340 against PrP were ob-
Figure 10. Proposed model of NCAM-to-PrP interactions
in NCAM/PrP-mediated neurite outgrowth. (A) In
NCAM
 /  (wt) neurons, at resting conditions PrP accumu-
lates in lipid rafts enriched in fyn. NCAM, which binds to
RPTP  outside of lipid rafts (omitted for clarity) and acti-
vates fyn (Bodrikov et al., 2005), is largely excluded from
lipid rafts. Application of bivalent NCAM-Fc or multiva-
lent NCAM antibodies to neurons induces clustering of
NCAM, resulting in its palmitoylation that redistributes
NCAM to lipid rafts (Niethammer et al., 2002). In lipid
rafts, cis interactions between NCAM and PrP further re-
cruit and stabilize NCAM in lipid microdomains activating
fyn via NCAM, and finally resulting in neurite outgrowth
that is enhanced over neurite outgrowth in the absence of
NCAM antibodies or NCAM-Fc. (B) Application of biva-
lent PrP-Fc to NCAM
 /  (wt) neurons to mimic trans inter-
actions between NCAM at the cell surface and PrP on
adjacent membranes and in the ECM of the brain also in-
duces clustering of NCAM, favoring its redistribution to
lipid rafts. Moreover, PrP-Fc may directly link NCAM to
lipid-enriched microdomains due to the interactions be-
tween PrP-Fc and lipids (Walmsley et al., 2003). NCAM
redistribution to lipid rafts results in fyn activation via
NCAM and in enhanced neurite outgrowth. (C) In
NCAM
 /  neurons, application of PrP-Fc is ineffective be-
cause PrP-Fc cannot act through its neuronal receptor
NCAM and thus the fyn-activating signal is lost, resulting
in neurite outgrowth that is not different from neurite out-
growth in the absence of PrP. (D) Application of PrP-Fc to
PrP
 /  neurons induces clustering of NCAM and bridging
it to lipid rafts favoring NCAM redistribution to lipid rafts,
fyn activation, and neurite outgrowth (similarly to B). (E)
Application of NCAM-Fc or NCAM antibodies to PrP
 / 
neurons induces clustering of NCAM and its redistribution
to lipid rafts via palmitoylation of the NCAM intracellular
domain. However, NCAM redistribution to lipid rafts in
PrP
 /  neurons is reduced because NCAM/PrP cis inter-
actions stabilizing NCAM in lipid rafts are lost. This results
in reduced levels of fyn activation and neurite outgrowth
when compared with PrP
 /  neurons. (F) PrP antibodies
applied to neurons induce clustering of PrP, but not fyn
activation and neurite outgrowth induction because PrP
does not have a fyn-activating signal. PrP antibodies
block cis interactions between PrP and NCAM, thereby
inhibiting NCAM-mediated neurite outgrowth.JCB • VOLUME 169 • NUMBER 2 • 2005 352
tained from Dr. Man Sun Sy (Case Western Reserve University, Cleveland,
OH); mouse mAbs against PI(4,5)P2 were from Dr. Kiyoko Fukami (Univer-
sity of Tokyo, Tokyo, Japan). Rat mAbs 555 against L1 were used in the
ELISA binding assay and immunoblotting (Appel et al., 1993). The mAbs
735 against PSA have been described elsewhere (Frosch et al., 1985).
Goat pAbs m20 against PrP and rabbit pAbs and mouse mAbs against
fyn protein were from Santa Cruz Biotechnology, Inc. Rabbit pAbs against
phosphorylated Tyr416 recognizing activated fyn were from Cell Signal-
ing Technology. Cholera toxin B subunit labeled with fluorescein was pur-
chased from Sigma-Aldrich. Secondary antibodies against rabbit, rat, and
mouse Ig coupled to Cy2, Cy3, or Cy5 were from Dianova.
Animals
PrP
 /  mice (Bueler et al., 1992; Weiss et al., 1997; Chen et al., 2003)
were provided by Dr. Martin H. Groschup (Institute for Novel and Emerg-
ing Infectious Diseases, Greifswald, Germany) and Dr. Charles Weiss-
mann (MRC Prion Unit, Institute of Neurology, London, UK). NCAM
 / 
mice were provided by Dr. Harold Cremer (Cremer et al., 1994). Both
mutants were inbred for at least nine generations onto the C57BL/6J back-
ground. In the majority of experiments age-matched wild-type and mutant
mice were used. Observed differences were also verified in experiments
with wild-type and mutant littermates obtained from heterozygous breed-
ing pairs that showed the same effects. In particular, levels of NCAM140
and NCAM180 in lipid rafts from PrP
 /  littermates were 34.8   2.4%
with PrP
 /  values set to 100%. Ratio of activated fyn to total fyn protein
in the brain homogenates was 63.6   6.7% for PrP
 /  littermates with
PrP
 /  values set to 100%.
Culture and transfection of hippocampal neurons
Cultures of hippocampal neurons were prepared from 1–3-d-old C57BL/6J
mice or from NCAM
 /  or PrP
 /  mice. For immunocytochemical experi-
ments, neurons were grown in 10% horse serum on glass coverslips
coated with 100  g/ml poly-L-lysine in conjunction with 20  g/ml laminin
(Sytnyk et al., 2002). In experiments with stimulation of live neurons, 4
 g/ml NCAM-Fc or 2  g/ml PrP-Fc was applied for 20 min. Control neu-
rons were treated with 8  g/ml human Fc. NCAM pAbs were applied to
live neurons for 15 min followed by secondary antibodies applied for 5 min,
all in a CO2 incubator. Control neurons were treated with 10  g/ml non-
immune rabbit IgG. Neurons were transfected with GFP (CLONTECH Lab-
oratories, Inc.) or mouse PrP (Lehmann and Harris, 1995) 6 h after plating
using LipofectAMINE 2000 (Invitrogen) according to the manufacturer’s
instructions. Neurite outgrowth was assayed as described previously
(Niethammer et al., 2002). In brief, neurons were incubated for 24 h
with 2  g/ml PrP-Fc or 4  g/ml NCAM-Fc, with rabbit pAbs 340
against 10  g/ml or 30  g/ml PrP, or with goat pAbs m20 against
2  g/ml PrP, and lengths of the longest neurites were measured (Chen et
al., 1999). Control neurons were either treated with 8  g/ml human Fc or
10  g/ml nonimmune rabbit or goat IgG.
Detergent extraction of cultured neurons
Cells washed in PBS, pH 7.3, were incubated for 1 min in cold microtu-
bule-stabilizing buffer (MSB) (2 mM MgCl2, 10 mM EGTA, and 60 mM
Pipes, pH 7.0) and extracted 8 min on ice with 1% Triton X-100 in MSB
as described previously (Ledesma et al., 1998). After washing with PBS,
cells were fixed with cold 4% formaldehyde in PBS.
Immunofluorescence labeling
Indirect immunofluorescence staining was performed as described previ-
ously (Sytnyk et al., 2002; Leshchyns’ka et al., 2003). Primary antibodies
were detected with corresponding secondary antibodies coupled to Cy2,
Cy3, or Cy5 fluorochrome (Dianova). Clustering of NCAM was induced
by incubating live cells for 15 min (5% CO2 at 37 C) with NCAM anti-
bodies, and was visualized with secondary antibodies applied for 5 min
(Leshchyns’ka et al., 2003). Coverslips were embedded in Aqua-Poly/
Mount (Polysciences, Inc.). Images were acquired at RT using a confocal
laser scanning microscope (LSM510; Carl Zeiss MicroImaging, Inc.),
LSM510 software (version 3; Carl Zeiss MicroImaging, Inc.), and the oil
Plan-Neofluar 40  objective (NA 1.3; Carl Zeiss MicroImaging, Inc.) at
3  digital zoom. Contrast and brightness of the images were further ad-
justed in Corel Photo-Paint 9 (Corel Corporation).
Immunofluorescence quantification
Colocalization analysis was performed as described previously (Lesh-
chyns’ka et al., 2003). Images taken for quantification were acquired with
the same settings and were not further manipulated. We defined an
NCAM cluster as an accumulation of NCAM labeling with a mean inten-
sity at least 30% higher than background. NCAM clusters were outlined
using the threshold function of the Scion Image software (Scion Corpora-
tion). Within the outlined areas the mean intensities of NCAM and PrP,
GM1, PI(4,5)P2, or activated fyn labeling associated with NCAM clusters
were measured. The same threshold was used for all groups within one ex-
periment. To determine the mean intensity of the labeling along neurites,
neurites were manually outlined and the mean fluorescence intensity along
the neurites was measured using Scion Image software. Colocalization
profiles were analyzed using ImageJ software (National Institutes of
Health, Bethesda, MD). Correlation coefficients were calculated using Ex-
cel software (Microsoft).
Protein ligand binding assay
PrP-Fc containing the extracellular domain of the mouse PrP in fusion with
the Fc portion of human IgG or PrP-AP containing the extracellular domain
of the mouse PrP in fusion with AP was produced as described previously
(Chen et al., 2003). NCAM and L1 were purified from adult mouse brain
homogenate as described previously (Rathjen and Schachner, 1984; Pol-
lerberg et al., 1985). 5  g/ml PrP-Fc or 5  g/ml PrP-AP was immobilized
overnight on 96-well polyvinyl chloride plates (Nunc) in PBS. Wells were
then blocked for 1.5 h with PBS containing 3% BSA and incubated for 1.5 h
at RT with NCAM, L1, or NCAM-Fc (0–2  g/ml) diluted in PBS containing
0.05% Tween 20 (PBS-T) and 3% BSA. Plates were washed 3  with PBS-T
and incubated for 1.5 h at RT with pAbs against NCAM, mAbs against
L1, or pAbs against human Fc-tag (Jackson ImmunoResearch Laboratories)
in PBS-T containing 3% BSA. After washing with PBS-T, wells were incu-
bated with peroxidase-coupled secondary antibodies in PBS-T containing
3% BSA, washed 3 , and developed with 0.1% ABTS (Roche) in 100 mM
acetate buffer, pH 5.0. The reaction was stopped with 100 mM sodium
fluoride. OD was measured at 405 nm.
Culture and transfection of CHO cells
CHO cells were maintained in Glasgow modified Eagle’s medium con-
taining 10% FCS. Cells were stably transfected using LipofectAMINE Plus
reagent (Invitrogen), following the manufacturer’s instructions. NCAM140
expression vector was provided by Dr. Patricia Maness (University of
North Carolina, Chapel Hill, NC). 24 h after transfection, 1 mg/ml G418
was added to the culture medium, which was replaced with fresh medium
containing 1 mg/ml G418 every 3 d. After 3 wk in culture, single colo-
nies were selected for subsequent screening. In experiments with stimulation,
2  g/ml PrP-Fc or 8  g/ml human Fc were applied to live CHO cells for
20 min in a CO2 incubator.
Subcellular fractionation and isolation of lipid-enriched microdomains
Rafts were prepared from crude membrane and growth cone fractions
from 0–4-d-old mice as described previously (Leshchyns’ka et al., 2003).
The same protocol was used to isolate lipid rafts from CHO cells.
Chemical cross-linking
Crude membrane fractions or lipid rafts from 0–4-d-old mice were incu-
bated with 0.2 mM BS
3 cross-linker (Pierce Chemical Co.) in 20 mM so-
dium phosphate buffer (pH 7.6) for 30 min at RT. The cross-linking reaction
was stopped by the addition of 1 M Tris-HCl (pH 7.6) to a final concentra-
tion of 100 mM for 10 min. The cross-linked fractions were either sepa-
rated by gel electrophoresis and then immunoblotted or were used for
coimmunoprecipitation. Chemical cross-linking in brain homogenates with
PrP-Fc as bait was performed using Sulfo-SBED biotin label transfer reagent
(Pierce Chemical Co.), following the manufacturer’s instructions.
Coimmunoprecipitation
Homogenates were prepared from the brains of 0–4-d-old mice in 50 mM
Tris-HCl buffer (pH 7.5), containing 0.32 M sucrose, 1 mM CaCl2, 1 mM
MgCl2, and 1 mM NaHCO3. Samples containing 1 mg of protein were
lysed for 30 min in 50 mM Tris-HCl buffer (pH 7.5), containing 150 mM
NaCl, 0.5% Triton X-100, 1%  -octyl-D-glucopyranoside, 1 mM sodium
fluoride, 2 mM NaVO4, 0.1 mM PMSF, and EDTA-free protease inhibitor
cocktail (Roche). The lysis buffer containing this combination of detergents
completely solubilizes lipid rafts and has been used in a number of studies
involving coimmunoprecipitation of lipid raft components (Trupp et al.,
1999; Paratcha et al., 2001). Samples were then centrifuged for 15 min
at 20,000 g and 4 C. Supernatants were cleared with protein A/G-aga-
rose beads (Santa Cruz Biotechnology, Inc.) (for 3 h at 4 C) and incubated
with pAbs against NCAM, p59
fyn, or nonimmune rabbit Ig (overnight at
4 C), followed by precipitation with protein A/G-agarose beads (for 3 h
at 4 C). The beads were washed 3  with RIPA buffer, once with PBS, and
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mate percentage of NCAM molecules bound to PrP in the total brain mem-
branes (P) was quantified as: P   (NCAMIP/NCAMstart)   (PrPstart/PrPIP)  
100%, where NCAMstart and NCAMIP are labeling intensities of NCAM in
the total brain membranes and PrP immunoprecipitates, respectively, and
PrPstart and PrPIP are labeling intensities of PrP in the total brain membranes
and PrP immunoprecipitates, respectively.
Gel electrophoresis and immunoblotting
Proteins were separated by 8% SDS-PAGE and electroblotted onto nitro-
cellulose transfer membrane (PROTRAN; Schleicher & Schuell) overnight
at 5 mA. Immunoblots were incubated with appropriate primary antibod-
ies followed by incubation with peroxidase-labeled secondary antibodies
and were visualized using SuperSignal West Pico reagents (Pierce Chemi-
cal Co.) on BIOMAX film (Sigma-Aldrich). Molecular weight markers were
prestained protein standards from Bio-Rad Laboratories. Chemilumines-
cence was quantified using TINA 2.09 software (University of Manchester,
Manchester, UK). To allow quantitative comparisons of chemilumines-
cence between the lanes, the same amounts of total protein or equal
amounts of immunoprecipitates were loaded in each lane and the intensity
observed for the wild type was used for normalization. All preparations
(brain homogenates, immunoprecipitations, or lipid rafts) were performed
three times and at least two Western blots were performed with an individ-
ual sample (n   6). In each experiment, when PrP
 /  and PrP
 /  brains
were compared, PrP
 /  values were set to 1, and intensities for PrP
 / 
brains were normalized to PrP
 /  values. Values of all experiments were
used to calculate mean values and SEM.
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